Diafir Overview
- Year Founded
-
2011

- Status
-
Private
- Employees
-
3

- Latest Deal Type
-
Crowdfunding
- Latest Deal Amount
-
$956K
- Investors
-
7
Diafir General Information
Description
Developer of biological analytical tools designed to detect chronic liver disease, infections, or tumours and other Point of care (POC) diagnoses. The company offers infrared fiber sensor technology made by using chalcogenide glasses that offer rapid responses for chronic and infectious diseases, for better patient care and management, enabling physicians to get more accurate diagnosis results.
Contact Information
Website
www.diafir.comCorporate Office
- Lorans Park, 26J
- Avenue Chardonnet
- 35000 Rennes
- France
Corporate Office
- Lorans Park, 26J
- Avenue Chardonnet
- 35000 Rennes
- France
Diafir Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Equity Crowdfunding | $956K | Completed | Generating Revenue | |||
6. Seed Round | 09-Jun-2021 | Completed | Generating Revenue | |||
5. Later Stage VC | 13-Dec-2018 | Completed | Generating Revenue | |||
4. Early Stage VC | 14-Jan-2015 | Completed | Generating Revenue | |||
3. Grant | 21-Jul-2014 | Completed | Generating Revenue | |||
2. Early Stage VC | 09-May-2012 | $394K | $394K | Completed | Startup | |
1. Accelerator/Incubator | Completed | Startup |
Diafir Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
P Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Diafir Patents
Diafir Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20160356705-A1 | Device generating evanescent waves, and method for the implementation thereof | Active | 27-Jan-2014 | ||
ES-2656770-T3 | Evanescent wave device and commissioning procedure | Active | 27-Jan-2014 | ||
US-10054540-B2 | Device generating evanescent waves, and method for the implementation thereof | Active | 27-Jan-2014 | ||
CA-2937725-A1 | Device generating evanescent waves, and method for the implementation thereof | Active | 27-Jan-2014 | ||
CA-2937725-C | Device generating evanescent waves, and method for the implementation thereof | Active | 27-Jan-2014 | G01N21/431 |
Diafir Signals
Diafir Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Bpifrance | Sovereign Wealth Fund | Minority | ||
Laurent Calvez | Angel (individual) | Minority | ||
Xiang-Hua Zhang | Angel (individual) | Minority | ||
BioMaryland Center | Corporation | |||
Medicen | Corporation |
Diafir FAQs
-
When was Diafir founded?
Diafir was founded in 2011.
-
Where is Diafir headquartered?
Diafir is headquartered in Rennes, France.
-
What is the size of Diafir?
Diafir has 3 total employees.
-
What industry is Diafir in?
Diafir’s primary industry is Diagnostic Equipment.
-
Is Diafir a private or public company?
Diafir is a Private company.
-
What is Diafir’s current revenue?
The current revenue for Diafir is
. -
How much funding has Diafir raised over time?
Diafir has raised $3.27M.
-
Who are Diafir’s investors?
Bpifrance, Laurent Calvez, Xiang-Hua Zhang, BioMaryland Center, and Medicen are 5 of 7 investors who have invested in Diafir.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »